Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To provide long term follow-up and safety data in patients receiving Herceptin® following completion of a global Roche sponsored Herceptin® trial.
Critère d'inclusion
- To continue to provide treatment to those patients that may still be on treatment at the moment of the final data base closure/clinical cut-off of a clinical trials in which Herceptin® is investigated and that further benefit from treatment with Herceptin®